Explore All Access
Check if your research matches the topics covered in FASEB BioAdvances?
- Degree of match
- Common matching concepts
- Additional journal recommendations
FASEB BioAdvances : Impact Factor & More
eISSN: 2573-9832pISSN: 2573-9832
Open AccessShare this on:
Check your submission readiness
Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.
FASEB BioAdvances Key Metrics
CiteScore 
2.6
SNIP
0.77
Time to Publish
View Chart Mo
Topics Covered on FASEB BioAdvances
Ablation
genomic DNA
Learning environment
Cardiovascular care
Medical education
Biomedical sciences
Extracellular vesicles
Educational leadership
Immune system
Cancer gene
Pandemic
Urine
Medical curriculum
Student engagement
Medulloblastoma
Obstructive sleep apnea
Mutant
Overlap syndrome
Positive deviance
Vismodegib
FASEB BioAdvances Journal Specifications
| Overview | |
| Publisher | WILEY |
| Language | English |
| Frequency | Monthly |
| Article Processing Charges | EUR 2200 | GBP 1850 | USD 2400 |
| Publication Time | 10 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Society/Institute/Sponsor | Federation of American Societies for Experimental Biology |
| Frequency | Monthly |
| Publication Start Year | 2019 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors |
View less
One subscription packed with expert publication services and AI tools to get you published
Brought to you by 
Journal Selection Service
Benefit from our experts' recommendations of 3-5 best-suited journals, accompanied by a detailed Journal Selection report explaining the choices. Make informed decisions.
Journal Submission Service
Streamline your submission process with meticulous manuscript formatting to meet journal guidelines, crafting a tailored cover letter for the editor, and hassle-free account creation and submission
Bundle of AI tools for your research needs
Journal Finder, Paperpal, R Discovery, MindTheGraph and more
Time to Publish
% of papers by time taken from submission to publication
0 to 3 months43%
4 to 6 months40%
7 to 9 months10%
Above 9 months8%
Did you find this useful?
Planning to publish in FASEB BioAdvances ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in FASEB BioAdvances
Cardiac lipotoxicity and fibrosis underlie impaired contractility in a mouse model of metabolic dysfunction‐associated steatotic liver disease
- 28 Mar 2024
- FASEB BioAdvances
The m6 RNA methylation regulator KIAA1429 is associated with autophagy‐mediated drug resistance in lung cancer
- 15 Mar 2024
- FASEB BioAdvances
Club cell‐specific telomere protection protein 1 (<scp>TPP1</scp>) protects against tobacco smoke‐induced lung inflammation, xenobiotic metabolic dysregulation, and injurious responses
- 15 Jan 2024
- FASEB BioAdvances
Effect of air–liquid interface on cultured human intestinal epithelial cells
- 21 Dec 2023
- FASEB BioAdvances
Mustn1 ablation in skeletal muscle results in functional alterations.
- 15 Nov 2023
- FASEB bioAdvances
Increased lethality of respiratory infection by <i>Streptococcus pneumoniae</i> in the Dp16 mouse model of Down syndrome
- 30 Oct 2023
- FASEB BioAdvances
Cardiac lipotoxicity and fibrosis underlie impaired contractility in a mouse model of metabolic dysfunction‐associated steatotic liver disease
- 28 Mar 2024
- FASEB BioAdvances
The m6 RNA methylation regulator KIAA1429 is associated with autophagy‐mediated drug resistance in lung cancer
- 15 Mar 2024
- FASEB BioAdvances
Club cell‐specific telomere protection protein 1 (<scp>TPP1</scp>) protects against tobacco smoke‐induced lung inflammation, xenobiotic metabolic dysregulation, and injurious responses
- 15 Jan 2024
- FASEB BioAdvances
Effect of air–liquid interface on cultured human intestinal epithelial cells
- 21 Dec 2023
- FASEB BioAdvances
Mustn1 ablation in skeletal muscle results in functional alterations.
- 15 Nov 2023
- FASEB bioAdvances
Increased lethality of respiratory infection by <i>Streptococcus pneumoniae</i> in the Dp16 mouse model of Down syndrome
- 30 Oct 2023
- FASEB BioAdvances
Compare Similar Journals with FASEB BioAdvances
Select Journals to Compare with FASEB BioAdvances
Total journals - 7
You can select up to 3 Journals at a time
PLoS ONE
Publisher: PUBLIC LIBRARY SCIENCE
Scientific Reports
Publisher: NATURE PORTFOLIO
Academic Medicine
Publisher: LIPPINCOTT WILLIAMS & WILKINS
International Journal of Environmental Research and Public Health
Publisher: Multidisciplinary Digital Publishing Institute (MDPI)
International Journal of Molecular Sciences
Publisher: MDPI
Frontiers in Immunology
Publisher: FRONTIERS MEDIA SA
Proceedings of the National Academy of Sciences of the United States of America
Publisher: NATL ACAD SCIENCES
0 Journals Selected to compare with
FASEB BioAdvances
Compare journals across 7 parameters SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
Get detailed Journal comparison report on your email by signing up
FAQs on FASEB BioAdvances
How long has FASEB BioAdvances been actively publishing? 
FASEB BioAdvances has been in operation since 2019 till date.
What is the publishing frequency of FASEB BioAdvances?
FASEB BioAdvances published with a Monthly frequency.
How many articles did FASEB BioAdvances publish last year?
In 2023, FASEB BioAdvances publsihed 25 articles.
What is the eISSN & pISSN for FASEB BioAdvances?
For FASEB BioAdvances, eISSN is 2573-9832 and pISSN is 2573-9832.
What is Citescore for FASEB BioAdvances?
Citescore for FASEB BioAdvances is 2.6.
What is SNIP score for FASEB BioAdvances?
SNIP score for FASEB BioAdvances is 0.77.
Who is the publisher of FASEB BioAdvances?
WILEY is the publisher of FASEB BioAdvances.
